To characterize real-world patient profiles and safety-related diagnoses from the first 10,000 eyes receiving the dexamethasone intracanalicular insert indicated for the treatment of ocular inflammation and pain following ophthalmic surgery (DEX).

To evaluate the clinical outcomes of scleral fixation using the flanged belt-loop technique in patients with in-the-bag intraocular lens (IOL) subluxation following cataract surgery.

To examine all recalls of artificial tears from 2014-2025 in order to identify the most common types, classes of products, and associated reasons for recalls, and to provide guidance on safety.

To introduce an open-source calculator for quantifying lens tilt and decentration using swept-source anterior segment optical coherence tomography (SS-AS-OCT) images, and to evaluate its reproducibility and independence from evaluator experience.

To create a classification for cataractous eyes based on their ocular biometry and thus provide a standard to stratify eyes when evaluating intraocular lens (IOL) formulae performance in different groups.

To compare the ocular biometry and refractive outcome between two optical biometers.

To evaluate visual outcomes in patients with myopia or compound myopic astigmatism in wavefront-guided laser in situ keratomileusis (WFG-LASIK) and photorefractive keratectomy (WFG-PRK) performed by cornea fellows in training.

To compare two dispersive ophthalmic viscosurgical devices (OVD), Z-HYALCOAT (investigational) and HEALON EndoCoat (control), with a 3-month postoperative follow-up.

Toxic anterior segment syndrome (TASS) and postoperative endophthalmitis are rare but serious complications of intraocular surgery. Real-world incidence data from high-volume ambulatory surgical centers (ASCs) remain limited. We retrospectively analyzed 190,005 consecutive eyes undergoing cataract surgery or refractive lens exchange between January 2022 and April 2025 across 54 ASC sites. All cases were performed by 172 surgeons using standardized perioperative and sterilization protocols. Suspected TASS and endophthalmitis events were independently validated and centrally reviewed. Ten TASS cases were identified (0.0053%; 95% CI, 0.0029-0.0097%), including one bilateral case, all resolving with topical corticosteroids. Three endophthalmitis cases occurred (0.0016%; 95% CI, 0.0005-0.0046%), each managed successfully with intravitreal antibiotics and vitrectomy as indicated. No clustering was observed. The incidence of TASS and endophthalmitis in this national ASC network was markedly lower than reported in hospital-based studies. These findings support the safety of standardized high-volume ASC environments, including immediate sequential bilateral surgery.

To evaluate the prediction accuracy of the Barrett Universal II (BUII) intraocular lens (IOL) formula variations, including optional biometric parameters and sum-of-segments (SOS) axial length (AL) modification, for IOL power calculation in cataract surgery.

To identify risk factors for reverse pupillary block (RPB) by retrospectively analyzing anterior segment OCT (AS-OCT) images following intraocular lens (IOL) fixation surgery.

Age-related macular degeneration (AMD) and cataracts commonly coexist in the aging population, posing unique diagnostic and therapeutic challenges for ophthalmologists. While cataract surgery can substantially improve visual function, outcomes are often influenced by the type and severity of underlying macular pathology. This narrative review explores current evidence on the impact of cataract surgery in AMD patients, including preoperative assessment strategies, intraoperative considerations, and postoperative visual expectations. The role of multimodal imaging in detecting subclinical macular changes, advanced intraocular lenses, and the debated relationship between cataract surgery and AMD progression are discussed. Emphasis is placed on personalized patient selection and counseling to optimize outcomes. Overall, with appropriate planning and patient-centered care, cataract surgery remains a safe and beneficial intervention for most individuals with AMD.

To evaluate clobetasol propionate ophthalmic suspension (CPN) as treatment for inflammation and pain after cataract surgery.